Immediate Impact
4 from Science/Nature 57 standout
Citing Papers
Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
2025 Standout
Cancer immune evasion, immunoediting and intratumour heterogeneity
2025 Standout
Works of Xingxing Qi being referenced
Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials
2020
A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+ hepatocellular carcinoma (r/r GPC3+ HCC).
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Xingxing Qi | 252 | 50 | 52 | 162 | 129 | 11 | 450 | |
| Bihui Cao | 260 | 68 | 34 | 217 | 115 | 18 | 488 | |
| Gerry Gin Wai Kwok | 328 | 48 | 59 | 126 | 101 | 10 | 487 | |
| Liesbeth M. Veenendaal | 150 | 91 | 93 | 64 | 119 | 13 | 461 | |
| Yanan Gao | 157 | 93 | 24 | 188 | 78 | 11 | 472 | |
| Daijing Yuan | 299 | 13 | 14 | 144 | 77 | 10 | 377 | |
| Petros Fessas | 335 | 61 | 48 | 141 | 161 | 14 | 511 | |
| Emilien Loeuillard | 206 | 99 | 210 | 147 | 47 | 14 | 456 | |
| Daniel H. Li | 189 | 34 | 24 | 98 | 32 | 12 | 407 | |
| Wei Weng | 111 | 50 | 41 | 115 | 75 | 18 | 448 | |
| Junki Maehara | 185 | 103 | 52 | 98 | 137 | 17 | 438 |
All Works
Loading papers...